Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2003 5(4):255-260; DOI:10.1215/S1152851703000012
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kayl, A. E.
Right arrow Articles by Meyers, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Clinical Therapy Trials-Quality of Life

Does brain tumor histology influence cognitive function?

Anne E. Kayl1 and Christina A. Meyers

The University of Texas M.D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, TX 77030

1 Address correspondence to Anne E. Kayl, University of Texas M.D. Anderson Cancer Center, Department of Neuro-Oncology (431), 1515 Holcombe Blvd., Houston, TX 77030 (akayl{at}mail.mdanderson.org).

Abstract

This retrospective study investigated the relationship between tumor histology and postsurgical cognitive function in patients diagnosed with malignant brain tumors. The neuropsychological functioning of 24 adult patients diagnosed with glioblastoma multiforme (GBM) was compared with the neuropsychological functioning of 24 adult patients diagnosed with anaplastic astrocytoma (AA). The groups were matched with respect to patient age, gender, and education, as well as tumor location and tumor volume. The mean raw test scores of the AA patient group were superior to the mean scores of the GBM patient group on nearly all measures administered. However, significant performance differences were not detected for any of 5 neuropsychological domain scores (Intellectual, Language, Memory, Executive, and Motor Function). Analysis of covariance (ANCOVA) revealed that tumor histology was not a significant predictor of domain score after controlling for tumor volume. Multiple regression and correlation analyses supported the results of the ANCOVA by offering further evidence of weak relationships between tumor type, tumor volume, and neuropsychological test scores. We conclude that tumor histology is not clearly predictive of cognitive performance in adults with AA and GBM.




This article has been cited by other articles:


Home page
Neuro OncolHome page
I. Bosma, M. J. Vos, J. J. Heimans, M. J.B. Taphoorn, N. K. Aaronson, T. J. Postma, H. M. van der Ploeg, M. Muller, W. P. Vandertop, Ben. J. Slotman, et al.
The course of neurocognitive functioning in high-grade glioma patients
Neuro-oncol, January 1, 2007; 9(1): 53 - 62.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2003 by Society for Neuro-Oncology